20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Humatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…
Read more
Humatica has been named a finalist for the Actum Awards as Value Creation Firm of the Year (People and Organisational Strategy) and for the Real Deals Private Equity Awards 2025 in…
Read more
2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…
Read more
